Bioactive coating would increase the effectiveness of masksA Quebec-Brazilian research team has developed a bioactive coating for surgical masks that not only blocks viruses but also destroys them. Immunotherapy safe for HIV-positive patients with cancer, study showsConcerns that HIV-positive patients may not respond adequately to treatment or experience harmful side-effects may be unfounded. Management of oral thrush Oral candidiasis is an opportunistic fungal infection of the oral mucosa. 1 in 9 Canadian adults have had long term symptoms from COVID infection, StatCan says Almost 80% of those people with long-term symptoms have them for six months or more, the report said. Growing evidence that influenza vaccine protects against cardiovascular diseases Canadian healthcare providers should mention cardiovascular disease prevention as a benefit when promoting the usefulness of flu vaccines to the public. More risk of C. difficile in hospitalized patients taking antidepressants Given the increasingly widespread use of antidepressants, researchers believe more attention should be paid to the risks for hospitalized patients. HIV diagnoses hit 10-year high in Montreal, cases more than double between 2021-22 Data shared last week shows the number of new reported HIV cases more than doubled between 2021 and 2022, to 310 from 141. Preventive use of amikacin can reduce cases of ventilator-acquired pneumonia Researchers are now evaluating the possibility of starting preventive antibiotics after four or five days of ventilation. Antibiotic resistance linked to malnutrition in Canadian study Deficiencies in certain micronutrients lead to significant changes in the gut microbiota that could promote antibiotic resistance. Health Canada authorizes updated Novavax COVID-19 vaccine targeting XBB variant The new vaccine is called Nuvaxovid and is approved for people 12 years of age and over. First Previous 25 26 27 28 29 Next Last
